T1	Participants 272 522	for childhood acute lymphoblastic leukaemia (UKALL X) randomised patients aged 0-14 years inclusive with an initial white blood count of less than 100 x 10(9)/l to receive an early intensification block, a late intensification block, both, or neither
T2	Participants 554 578	children aged 1-14 years
T3	Participants 689 701	all patients
